Gene transfer of IκBα limits infarct size in a mouse model of myocardial ischemia-reperfusion injury

Laboratory Investigation

Volumn 83, Issue 8, 2003, Pages 1097-1104

  Squadrito, Francesco ^a   Deodato, Barbara ^a   Squadrito, Giovanni ^a   Seminara, Paolo ^a   Passaniti, Maria ^a   Venuti, Francesco S ^a   Giacca, Mauro ^a   Minutoli, Letteria ^a   Adamo, Elena B ^a   Bellomo, Maria ^a   Marini, Rolando ^a   Galeano, Mariarosaria ^b   Marini, Herbert ^a   Altavilla, Domenica ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; ELASTASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PARVOVIRUS VECTOR; VIRUS VECTOR; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PANCREATIC ELASTASE; PRIMER DNA;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVITY; GENE TRANSFER; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; REPERFUSION INJURY; VIRAL GENE THERAPY; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; C57BL MOUSE; CHEMISTRY; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; HEART INFARCTION; HEART VENTRICLE; METABOLISM; METHODOLOGY; PATHOLOGY; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; DNA PRIMERS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEART VENTRICLES; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NF-KAPPA B; PANCREATIC ELASTASE; RNA, MESSENGER; TRANSDUCTION, GENETIC;

EID: 0043236476     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000082060.39079.A6     Document Type: Article

References (38)

1. Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G, Saitta A, Cucinotta D, Ceccarelli S, Ferlito M, Tringali M, Minutoli L, Caputi AP, and Squadrito F (2000). IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-κB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 47:515-528.
2. Altavilla D, Saitta A, Guarini S, Galeano M, Squadrito G, Cucinotta D, Santamaria LB, Mazzeo AT, Campo GM, Ferlito M, Minutoli L, Bazzani C, Bertolini A, Caputi A, and Squadrito F (2001). Oxidative stress causes nuclear factor-kappaB activation in acute hypovolemic hemorrhagic shock. Free Radic Biol Med 30:1055-1066.
3. Altavilla D, Squadrito F, Ioculano M, Canale P, Campo GM, Zingarelli B, and Caputi AP (1994). E-selectin in the pathogenesis of experimental myocardial ischaemia-reperfusion injury. Eur J Pharmacol 3:45-51.
4. Braun E (1985). Myocardial reperfusion: A double-edged sword? J Clin Invest 35:1713-1719.
5. Brown K, Park S, Kanno T, Franzoso G, and Sienbelist U (1993). Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc Natl Acad Sci USA 90:2532-2536.
6. Chandrasekar B, Nelson JF, Colston JT, and Freeman GL (2001a). Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury. Am J Physiol 280:H2094-H20102.
7. Chandrasekar B, Smith JB, and Freeman GL (2001b). Ischemia-reperfusion of rat myocardium activates nuclear factor KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103;2296-2302.
8. Ghosh S, May MJ, and Kopp EB (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
9. Gius D, Botero A, Shah S, and Curry HA (1999). Intracellular oxidation/reduction status in the regulation of transcription factor NF-kappa B and AP-1. Toxicol Lett 106:93-106.
10. Grimm D, Kern A, Rittner K, and Kleinschmidt JA (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 9:2745-2760.
11. Kupatt C, Habazetti H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, Kelly RA, and Becker BF (1999). Tumor necrosis factor-alpha contributes to ischaemia- and reperfusion-induced endothelial activation in isolated hearts. Circ Res 84(4):392-400.
12. Ikeda U, Ikeda M, Kano S, and Shimada K (1994). Neutrophil adherence to rat cardiac myocytes by pro-inflammatory cytokines. J Cardiovasc Pharmacol 23:647-652.
13. Ioculano M, Squadrito F, Altavilla D, Canale P, Squadrito G, Campo GM, Saitta A, and Caputi AP (1994). Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat. Eur J Pharmacol 264:143-149.
14. Lee J and Burckart GJ (1998). Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 38:981-993.
15. Li C, Browder W, and Kao RL (1999). Early activation of transcription factor NF-kappa B during ischaemia in perfused rat heart. Am J Physiol 276:H543-H552.
16. Lucchesi BR (1990). Modulation of leukocyte mediated myocardial reperfusion injury. Annu Rev Physiol 52:561-576.
17. Lucchesi BR (1991). Modulation of leukocyte-mediated myocardial ischaemia reperfusion injury. Annu Rev Physiol 84:400-411.
18. McCord JM (1987). Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed Proc 46:2402-2406.
19. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, and Dzau VJ (2002). Gene therapy strategy for long term myocardial protection using adeno-associated virus mediated delivery of heme oxygenase gene. Circulation 105(5):602-607.
20. Monahan PE and Samulski RJ (2000). AAV vectors: Is clinical success on the horizon? Gene Ther 7:24-30.
21. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, and Ogihara T (1997). In vivo transfection of cis element "decoy" against nuclear factor kappaB binding site prevents myocardial infarction. Nat Med 3(8):894-899.
22. Mullane K (1991). Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc Med 1:282-289.
23. Muller DW, Topo EJ, Califf RM, Sigmon KN, Gorman L, George BS, Kereiakes DJ, Lee KL, and Ellis SG (1990). Relationship between antecedent angina pectoris and prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 119:224-231.
24. Phillips MI, Tang Y, Schmidt-Ott K, Qian K, and Kagiyana S (2002). Vigilant vector: Heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 39(2):651-655.
25. Sakaguchi T, Sawa Y, Fukushima N, Nishimura M, Ichikawa H, Kaneda Y, and Matsuda H (2001). A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation. Ann Thorac Surg 71(82):624-629.
26. Sawa Y, Morishita R, Suzuki K, Kagisaki K, Kaneda Y, Maeda K, Kadoba K, and Matsuda H (1997). A novel strategy for myocardial protection using in vivo transfection of cis element "decoy" against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. Circulation 96(9 Suppl):11280-11284.
27. Squadrito F, Altavilla D, Squadrito G, Saitta A, Deodato B, Arlotta M, Minutoli L, Quartarone C, Ferlito M, and Caputi AP (2000). Tacrolimus limits polymorphonuclear leukocyte accumulation and protects against myocardial ischaemia-reperfusion injury. J Mol Cell Cardiol 32:429-440.
28. Squadrito F, Altavilla D, Zingarelli B, Ioculano M, Calapai G, Campo GM, Miceli A, and Caputi AP (1993). Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury. Eur J Pharmacol 237:223-230.
29. Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, and Hennekens CH (1982). Effect of intravenous streptokinase on acute myocardial infarction: Pooled results from randomized trials. N Engl J Med 307:1180-1182.
30. Stone GW, Brodie BR, Griffin JJ, Morice MC, Costantini C, St Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O'Neill WW, and Grines CL (1998). Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 31(1):23-30.
31. Su H, Lu R, and Kan YW (2000). Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 97:13801-13806.
32. Sun B, Fan H, Honda T, Fujimaki R, Lafond-Walker A, Masul Y, Lowenstein CJ, and Becker LC (2001). Activation of NF kappa B and expression of ICAM-1 in ischemic-reperfused canine myocardium. J Mol Cell Cardiol 33:109-119.
33. Thourani VH, Brar SS, Kennedy TP, Thornton LR, Watts JA, Ronson RR, Zhao Z, Sturrock AL, Hoidal JR, and Vinten-Johansen J (2000). Nonanticoagulant heparin inhibits NF-κB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 48:H2084-H2093.
34. Valen G, Yan ZQ, and Hansson GK (2001). Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307-314.
35. Yoshiyama M, Omura T, Takeuchi K, Kim S, Shimasa K, Yamagishi H, Teragaki M, Akioka K, Iwao H, and Yoshikawa J (2001). Angiotensin blockade inhibits increased JNKs, AP-1 and NF-kappa B DNA-binding activities in myocardial infarcted rats. J Mol Cell Cardiol 33:799-810.
36. Zabel U, Henkel T, Dos Santos Silva M, and Baeuerle PA (1993). Nuclear uptake control of NF-κB by MAD-3 and IκB protein present in the nucleus. EMBO J 12:201-211.
37. Zahn R, Koch A, Rustige J, Schiele R, and Wirtzfeld A (1997). Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction. ALKK Study Group. Am J Cardiol 79:264-269.
38. Zolotukhin S, Potter M, Hauswirth WW, Guy J, and Muzyczka N (1996). A "humanized" green fluorescent cDNA adapted for high-level expression in mammalian cells. J Virol 70:4646-4654.